Liquid biopsies to distinguish malignant from benign pulmonary nodules-Reference-Cited by-同舟云学术

Liquid biopsies to distinguish malignant from benign pulmonary nodules

Published:2021-05-07 Issue:11 Volume:12 Page:1647-1655
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Tao Rui¹,Cao Wei²,Zhu Feng³,Nie Jinfu⁴⁵,Wang Hongzhi⁴⁵,Wang Lixiang²,Liu Pengcheng¹,Chen Hailong¹,Hong Bo⁴⁵^ORCID,Zhao Dahai¹^ORCID

Affiliation:

1. Department of Respiratory and Critical Care Medicine the Second Affiliated Hospital, Anhui Medical University Hefei China

2. Department of Cardiothoracic Surgery the Second Affiliated Hospital, Anhui Medical University Hefei China

3. Department of Thoracic Surgery Anhui Chest Hospital, Thoracic Clinical College of Anhui Medical University Hefei China

4. Anhui Province Key Laboratory of Medical Physics and Technology Institute of Heath & Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences Hefei China

5. Hefei Cancer Hospital, Chinese Academy of Science Hefei China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13982

Reference72 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

3. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017

4. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018

5. Diagnosis and management of peripheral lung nodule

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG);eClinicalMedicine;2024-09

2. Commentary: It's all in the (cell-free) DNA: Risk stratification of high-risk pulmonary nodules;The Journal of Thoracic and Cardiovascular Surgery;2024-07

3. Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules;Heliyon;2024-05

4. A novel microRNA miR-4433a-3p as a potential diagnostic biomarker for lung adenocarcinoma;Heliyon;2024-05

5. Signal-On Fluorescence Biosensor for Detection of miRNA-21 Based on ROX labeled Specific Stem-Loop Probe;Iranian Journal of Pharmaceutical Research;2024-03-30